title: [City type MRSA infection].
authors.forename: Itaru
authors.initials: I
authors.lastname: Nakamura
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Yamaguchi
authors.forename: Yukihiko
authors.initials: Y
authors.lastname: Kato
authors.forename: Namiko
authors.initials: N
authors.lastname: Abe
authors.forename: Kazuto
authors.initials: K
authors.lastname: Hayashi
authors.forename: Kenichiro
authors.initials: K
authors.lastname: Mae
authors.forename: Aiko
authors.initials: A
authors.lastname: Fujiki
authors.forename: Ryoji
authors.initials: R
authors.lastname: Tsuboi
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Matsumoto
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D005260:Female; D005578:Fosfomycin / Q000627:therapeutic use; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology*; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D002981:Clindamycin; D014640:Vancomycin